US Broker Ratings

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth Challenges with Potential Upside

Investors keen on the healthcare sector might find Hologic, Inc. (HOLX) an intriguing prospect, given its pivotal role in medical instruments and supplies, particularly in women’s..

The Ensign Group, Inc. (ENSG) Investor Outlook: A Healthcare Stock with 20% Upside Potential

For investors seeking diversification within the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) offers a compelling opportunity. With a market capitalization of $7.86 billion, The..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 22.59% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a powerhouse in the healthcare sector, specifically within the drug manufacturing industry, is attracting investor attention with a potential upside of 22.59%...

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biopharma with Strong Revenue Growth and Investor Optimism

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector with a notable market capitalization of $6.02 billion. This commercial-stage biopharmaceutical company is making waves..

BrightSpring Health Services (BTSG) Investor Outlook: Exploring a Potential 40% Upside

BrightSpring Health Services, Inc. (BTSG) is a noteworthy contender in the Healthcare sector, specifically within the Health Information Services industry. With its roots firmly planted in..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 52.24% Potential Upside Amidst Biotechnology Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, continues to be a focal point for investors, especially with a potential upside of 52.24%..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 35.68% Upside Potential

Navigating the competitive waters of the biotechnology industry, Genmab A/S (NASDAQ: GMAB) continues to capture investor attention with its promising pipeline and solid financial metrics. Positioned..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating a Promising Future in Healthcare Innovation

Regencell Bioscience Holdings Limited (RGC) is a fascinating player in the healthcare sector, with a specific focus on Traditional Chinese Medicine (TCM) for neurocognitive disorders. Although..

Nuvalent, Inc. (NUVL) Investor Outlook: A Promising 40% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors with its robust pipeline of oncology therapies and a notable potential upside of over 40%. Despite..

AptarGroup, Inc. (ATR) Stock Analysis: Growth Potential and an 11.91% Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player within the Healthcare sector and the Medical Instruments & Supplies industry, offers a compelling proposition for investors seeking exposure..

Johnson & Johnson (JNJ) Stock Analysis: A Solid 3.40% Dividend Yield Amid Steady Growth

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to attract investor attention with its robust market position and a promising 3.40% dividend..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a Potential 15% Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, particularly in the medical device industry, has been a focus of investor attention due..

BioNTech SE (BNTX) Stock Analysis: Evaluating a Potential 23.60% Upside Amid Challenging Metrics

BioNTech SE, trading under the ticker BNTX, has become a prominent name in the biotechnology sector, particularly known for its advancements in immunotherapies targeting cancer and..

Takeda Pharmaceutical Company L (TAK): Investor Outlook with a 16.10% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, commands significant attention from investors with its robust pipeline and broad therapeutic portfolio. As..

Guardant Health, Inc. (GH) Stock Analysis: A 28.42% Potential Upside in the Precision Oncology Sector

Guardant Health, Inc. (NASDAQ: GH) is capturing the attention of investors with its promising position in the healthcare sector, specifically within diagnostics and research. Headquartered in..

The Cigna Group (CI) Investor Outlook: Unpacking a 26.93% Potential Upside

The Cigna Group (CI), a formidable player in the healthcare sector, presents a compelling opportunity for investors looking to capitalize on its robust financial metrics and..

Masimo Corporation (MASI) Stock Analysis: Exploring an 18.95% Potential Upside in Medical Devices

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, is steadfastly navigating the competitive landscape of the medical devices industry. Based in Irvine, California,..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Contender with 40.39% Potential Upside

Teleflex Incorporated (NYSE: TFX) is a noteworthy player in the healthcare sector, specializing in the development and supply of single-use medical devices for diagnostic and therapeutic..

Humana Inc. (HUM) Stock Analysis: Exploring a 34% Potential Upside Despite Recent Challenges

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, has been a household name in providing medical and specialty insurance products across the United..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Examining a 90% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing the attention of investors with its compelling potential upside of 90.36%. As a clinical-stage biotechnology company, Revolution Medicines, headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds